These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15714141)

  • 1. Enzyme content and acid stability of enteric-coated pancreatic enzyme products in vitro.
    Case CL; Henniges F; Barkin JS
    Pancreas; 2005 Mar; 30(2):180-3. PubMed ID: 15714141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A; Puccinelli D; Sarles J; Laugier R; Leblond Y; Carrière F
    Aliment Pharmacol Ther; 2008 Feb; 27(3):283-92. PubMed ID: 17973644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.
    Kuhn RJ; Eyting S; Henniges F; Potthoff A
    J Pediatr Pharmacol Ther; 2007 Apr; 12(2):115-28. PubMed ID: 23055848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancrease gastroresistance: in vitro evaluation of pH-determined dissolution.
    Lenaerts C; Beraud N; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S18-21. PubMed ID: 3404358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
    Qureshi SA; McGilveray IJ
    Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study.
    Shlieout G; Koerner A; Maffert M; Forssmann K; Caras S
    Clin Drug Investig; 2011; 31(7):e1-7. PubMed ID: 21627335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market.
    Shrikhande SV; Prasad VGM; Domínguez-Muñoz JE; Weigl KE; Sarda KD
    Drug Des Devel Ther; 2021; 15():3835-3843. PubMed ID: 34522087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel cross-linked lipase: impact of cross-linking on solubility and release from drug product.
    Hetrick EM; Sperry DC; Nguyen HK; Strege MA
    Mol Pharm; 2014 Apr; 11(4):1189-200. PubMed ID: 24606399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
    Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro enzyme activities of five commercially available pancreatic supplements.
    Shaw DW; Barbezat GO
    N Z Med J; 1982 Jun; 95(710):424-5. PubMed ID: 6180364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.
    Whitehead AM
    Pharm Weekbl Sci; 1988 Feb; 10(1):12-6. PubMed ID: 2451209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
    Lieb JG; Patel D; Karnik N; Toskes PP
    Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity.
    Hendeles L; Dorf A; Stecenko A; Weinberger M
    JAMA; 1990 May; 263(18):2459-61. PubMed ID: 2329633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
    Vantini I; Fioretta A; Bonfante F; Brentegnani MT; Benini L; Castellani G
    Clin Ter; 1993 May; 142(5):445-51. PubMed ID: 8339528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution of omeprazole from delayed-release solid oral dosage forms.
    Farinha A; Bica A; Martins JM; Pais JP
    Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.